299 related articles for article (PubMed ID: 21419057)
1. [Contact tracing and prophylaxis of tuberculosis].
Seersholm N; Wilcke T
Ugeskr Laeger; 2011 Mar; 173(12):883-6. PubMed ID: 21419057
[TBL] [Abstract][Full Text] [Related]
2. A prospective cohort study of latent tuberculosis in adult close contacts of active pulmonary tuberculosis patients in Korea.
Park SH; Lee SJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Kim HJ; Menzies D
Korean J Intern Med; 2016 May; 31(3):517-24. PubMed ID: 27052266
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of LTBI among household contacts of sputum positive TB patients receiving DOTS chemotherapy.
Praveen V
Indian J Tuberc; 2020 Oct; 67(4):459-465. PubMed ID: 33077044
[TBL] [Abstract][Full Text] [Related]
4. Predictors of contact tracing completion and outcomes in tuberculosis: a 21-year retrospective cohort study.
Saunders MJ; Koh GC; Small AD; Dedicoat M
Int J Tuberc Lung Dis; 2014 Jun; 18(6):640-6. PubMed ID: 24903932
[TBL] [Abstract][Full Text] [Related]
5. Tuberculosis contact tracing among children and adolescent referred to children's hospital in Rio de Janeiro, Brazil.
Mendonça AM; Kritski AL; Sant'Anna CC
Braz J Infect Dis; 2015; 19(3):296-301. PubMed ID: 25636186
[TBL] [Abstract][Full Text] [Related]
6. Acceptance of Chemo-prophylaxis for Latent Tuberculosis Infection among High School/College Student Contacts of Tuberculosis Patients in Shanghai, China.
Li Y; Zheng YH; Lu LP; Yang MX; Zhou CM; Yuan ZA; Hu Y; Xu B
Biomed Environ Sci; 2018 Apr; 31(4):317-321. PubMed ID: 29773096
[TBL] [Abstract][Full Text] [Related]
7. Optimizing the management of children with latent tuberculosis infection.
Venturini E; Tersigni C; Chiappini E; de Martino M; Galli L
Expert Rev Anti Infect Ther; 2017 Apr; 15(4):341-349. PubMed ID: 28074660
[TBL] [Abstract][Full Text] [Related]
8. Outbreak of isoniazid-resistant tuberculosis in an immigrant community in Spain.
Hernán García C; Moreno Cea L; Fernández Espinilla V; Ruiz Lopez Del Prado G; Fernández Arribas S; Andrés García I; Rubio V; Vesenbeckh S; Eiros Bouza JM
Arch Bronconeumol; 2016 Jun; 52(6):289-92. PubMed ID: 26584529
[TBL] [Abstract][Full Text] [Related]
9. National position statement for the management of latent tuberculosis infection.
Stock D;
Commun Dis Intell Q Rep; 2017 Sep; 41(3):E204-E208. PubMed ID: 29720068
[TBL] [Abstract][Full Text] [Related]
10. Latent infection treatment to prevent TB transmission in school settings.
Lee PH; Chang FY
J Formos Med Assoc; 2012 Oct; 111(10):525-6. PubMed ID: 23089686
[No Abstract] [Full Text] [Related]
11. [Neonatal exposure to active pulmonary tuberculosis in a maternity ward: screening and clinical course of a cohort of exposed infants].
Perry A; Angoulvant F; Chadelat K; De Lauzanne A; Houdouin V; Kheniche A; Lorrot M; Mesples B; Nouyrigat V; Aujard Y; Gaudelus J; Grimprel E; Faye A
Arch Pediatr; 2012 Apr; 19(4):396-403. PubMed ID: 22377245
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of latent infection with Mycobacterium tuberculosis.
Chee CB; Sester M; Zhang W; Lange C
Respirology; 2013 Feb; 18(2):205-16. PubMed ID: 23107218
[TBL] [Abstract][Full Text] [Related]
13. Low uptake of isoniazid window prophylaxis in patients exposed to a health-care worker with pulmonary tuberculosis in a paediatric ward.
Sinnathamby A; Ang S; Bagdasarian N; Chan HC; Chan SM
J Paediatr Child Health; 2021 Sep; 57(9):1408-1413. PubMed ID: 33847414
[TBL] [Abstract][Full Text] [Related]
14. Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak.
Lee SH; Lew WJ; Kim HJ; Lee HK; Lee YM; Cho CH; Lee EJ; Lee DY; Ryu SW; Oh SY; Kim SO; Shim TS
Respir Med; 2010 Mar; 104(3):448-53. PubMed ID: 19879123
[TBL] [Abstract][Full Text] [Related]
15. Assessment and management of active and latent TB.
Shepherd JG; Chapman ALN
Practitioner; 2016 Nov; 260(1798):21-4. PubMed ID: 28968052
[TBL] [Abstract][Full Text] [Related]
16. Risk for tuberculosis in child contacts. Development and validation of a predictive score.
Chan PC; Shinn-Forng Peng S; Chiou MY; Ling DL; Chang LY; Wang KF; Fang CT; Huang LM
Am J Respir Crit Care Med; 2014 Jan; 189(2):203-13. PubMed ID: 24304428
[TBL] [Abstract][Full Text] [Related]
17. [Screening for tuberculosis infection prior to medical therapy].
Ravn P
Ugeskr Laeger; 2011 Mar; 173(12):893-6. PubMed ID: 21419060
[TBL] [Abstract][Full Text] [Related]
18. A quantitative benefit-risk analysis of isoniazid for treatment of latent tuberculosis infection using incremental benefit framework.
Sadatsafavi M; Marra C; Marra F; Moran O; FitzGerald JM; Lynd L
Value Health; 2013; 16(1):66-75. PubMed ID: 23337217
[TBL] [Abstract][Full Text] [Related]
19. Drug therapy for children with tuberculosis.
Ormerod LP
Arch Dis Child; 2012 Dec; 97(12):1097-101. PubMed ID: 23104773
[TBL] [Abstract][Full Text] [Related]
20. Programmatic impact of using QuantiFERON®-TB Gold in routine contact investigation activities.
Grinsdale JA; Ho CS; Banouvong H; Kawamura LM
Int J Tuberc Lung Dis; 2011 Dec; 15(12):1614-20. PubMed ID: 22118167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
